Phase Ib SEASTAR Study: Combining Rucaparib and Sacituzumab Govitecan in Patients With Cancer With or Without Mutations in Homologous Recombination Repair Genes is a research paper published in JCO Precision Oncology (2022). On theSindex it has a DataRank of 0. It has been cited 30 times.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
National Institutes of Health
Grant: 3UL1TR003167-02S4
Center for Clinical and Translational Sciences (CCTS)
National Institutes of Health
Grant: 3P30CA006516-41S6
CANCER CENTER SUPPORT GRANT
National Institutes of Health
Grant: 3P30CA016672-41S4
Cancer Center Support (CORE) Grant
FWCI
2.43
Citation Percentile
0.9%
Citation Trend
Fields of Study
MeSH Terms
Keywords